Back
The Scotts Miracle Gro Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
51
SMG
The Scotts Miracle Gro
Last Price:
$59.41
Seasonality Move:
-2.34%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$17.45
Seasonality Move:
5.74%
Buy
51
The Scotts Miracle Gro (SMG)
is a Buy
Is The Scotts Miracle Gro a Buy, Sell or Hold?
-
The current The Scotts Miracle Gro [SMG] share price is $60.83. The Score for SMG is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
SMG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $17.78. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SMG Stock Price Chart
What is The Scotts Miracle Gro's stock price today?
-
The The Scotts Miracle Gro share price today is $60.83The current trend is moderately bullish and SMG is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $17.78Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.99 | Buy |
Relative Strength Index (14 RSI): | 60.29 | Buy |
Chaikin Money Flow: | 486459 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.33 - 59.85) | Buy |
Bollinger Bands (100): | (54.28 - 68.02) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.7 | Sell |
Relative Strength Index (14 RSI): | 44.9 | Sell |
Chaikin Money Flow: | 1310696 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.04 - 19.02) | Sell |
Bollinger Bands (100): | (19.37 - 29.83) | Sell |
SMG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.09 | Sell |
20-day SMA: | 56.93 | Buy |
50-day SMA: | 55.7 | Buy |
200-day SMA: | 68.97 | Sell |
8-day EMA: | 60.49 | Buy |
20-day EMA: | 58.07 | Buy |
50-day EMA: | 57.69 | Buy |
200-day EMA: | 64.45 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.4 | Buy |
20-day SMA: | 18.11 | Sell |
50-day SMA: | 20.11 | Sell |
200-day SMA: | 28.63 | Sell |
8-day EMA: | 17.67 | Buy |
20-day EMA: | 18.1 | Sell |
50-day EMA: | 20.2 | Sell |
200-day EMA: | 28.78 | Sell |
The Scotts Miracle Gro Earnings Growth & SMG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $3.55 per share, an increase this year of $0.90 per share, and an increase next year of $0.74 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
The Scotts Miracle Gro Technical Analysis
May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |